Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation

Transplantation

Volumn 82, Issue 5, 2006, Pages 709-711

  Walter, Joseph N ^a   Fan, Leland L ^b   Bag, Remzi ^b   Zhang, Haibin ^b   Doan, Minh ^b   Mallory, George B ^b   Elidemir, Okan ^b,c  

^a DRISCOLL CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Texas Children's Hospital   (United States)

Author keywords

Bronchiolitis obliterans; KL 6; Lung transplant

Indexed keywords

BIOLOGICAL MARKER; GLYCOPROTEIN; GLYCOPROTEIN KL 6; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; CHILD; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; GRAFT RECIPIENT; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADULT; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BRONCHIOLITIS OBLITERANS; CHILD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MUCINS; POSTOPERATIVE COMPLICATIONS;

EID: 33748710419     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000234952.46013.df     Document Type: Article

References (9)

1. Moffatt S, Demers P, Robbins R, et al. Lung Transplantation: A Decade of Experience. J Heart Lung Transplant 2005; 24: 145.
2. Boehler A, Estenne M. Post-transplant Bronchiolitis Obliterans. Eur Respir J 2003; 22: 1007.
3. Estenne M, Hertz MI. Bronchiolitis Obliterans after Human Lung Transplantation. Am J Resp Crit Care Med 2002; 166: 440.
4. Hermans C, Bernard A. Lung Epithelium-specific Proteins. Am J Resp Crit Care Med 1999; 159: 646.
5. Shimizu Y, Hamada T, Tanaka Y, et al. Colocalization of CA 19-9 and KL-6 to epithelial cells in dilated bronchioles in a patient with idiopathic pulmonary fibrosis complicated by diffuse alveolar damage. Respirology 2002; 7: 281.
6. Al-Salmi QA, Walter JN, Colasurdo GN, et al. Serum KL-6 and Surfactant Proteins A and D in Pediatric Interstitial Lung Disease. CHEST 2005; 127: 403.
7. Ohnishi H, Yokoyama A, Kondo K, et al. Comparative Study of KL-6, Surfactant Protein-A, Surfactant Protein-D, and Monocyte Chemoattractant Protein-1 as Serum Markers for Interstitial Lung Diseases. Am J Resp Crit Care Med 2002; 165: 378.
8. Imai T, Takase M, Takeda S, et al. Serum KL-6 Levels in Pediatric Patients: Reference Values for Children and Levels in Pneumonia, Asthma and Measles Patients. Pediatric Pulmonology 2002; 33: 135.
9. Hirasawa Y, Kohno N, Yokoyama A, et al. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997; 17: 501.